Mumbai, January 13, 2026
Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650) on Tuesday announced the launch of its Centre of Genomics, strengthening its capabilities in advanced genomics, molecular diagnostics, precision medicine, and genomic research, as the company sharpens its focus on high-impact, data-driven diagnostics.The newly launched Centre of Genomics brings together Metropolis’ existing genomics strengths under a unified national framework aimed at delivering clinically actionable genomic insights across the care continuum. The initiative targets key clinical specialties, including oncology, reproductive health, neurology, transplant immunology, and rare diseases, positioning genomics as a core growth engine for...